Skip to main content
SpringerLink
Log in

Defining the role of ultrafiltration therapy in acute heart failure: a systematic review and meta-analysis

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Ultrafiltration (UF) has emerged as an alternative therapy for acute decompensated heart failure (ADHF) due to its physiological benefits such as improvement in neurohormonal activation. We performed a systematic review and a meta-analysis to evaluate the efficacy, safety, and the impact on outcomes for UF therapy as compared to conventional medical treatment. The PubMed and Cochrane databases were searched from inception to December 2015 for randomized controlled trials that examined UF therapy in ADHF and used diuretic-based regimens as the control group. In accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, we explored the impact on weight change, fluid removal, renal function, rehospitalization rate, and mortality. Mantel–Haenszel odds ratio (OR) was calculated for dichotomous data and weighted mean difference (WMD) for continuous data. Seven studies with a total of 771 patients met our selection criteria. UF therapy led to greater weight loss (WMD 1.35, 95 % CI 0.49–2.21, p < 0.01) and fluid removal (WMD 1.81, 95 % CI 1.01–2.62, p = <0.01) while the impact of UF on renal function was comparable with medical treatment (WMD 0.06, 95 % CI −0.11 to 0.22, p = 0.48), UF decreased heart failure rehospitalization rate (OR 0.60, 95 % CI 0.37–0.98, p = 0.04) but did not change mortality (OR 1.03, 95 % CI 0.68–1.57, p = 0.89). Compared with diuretic-based medical treatment, UF therapy is more efficient in decongestion of patients with ADHF. It does not have a deleterious impact on renal function and can improve heart failure-related rehospitalization rate, albeit without conferring a survival benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM et al (2013) Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6(3):606–619. doi:10.1161/HHF.0b013e318291329a

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kazory A (2013) Cardiorenal syndrome: ultrafiltration therapy for heart failure—trials and tribulations. Clin J Am Soc Nephrol 8(10):1816–1828. doi:10.2215/cjn.02910313

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bart BA, Boyle A, Bank AJ, Anand I, Olivari MT, Kraemer M, Mackedanz S, Sobotka PA, Schollmeyer M, Goldsmith SR (2005) Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 46(11):2043–2046. doi:10.1016/j.jacc.2005.05.098

    Article  PubMed  Google Scholar 

  4. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49(6):675–683. doi:10.1016/j.jacc.2006.07.073

    Article  CAS  PubMed  Google Scholar 

  5. Hanna MA, Tang WH, Teo BW, O’Neill JO, Weinstein DM, Lau SM, Van LenteF, Starling RC, Paganini EP, Taylor DO (2012) Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congest Heart Fail 18(1):54–63. doi:10.1111/j.1751-7133.2011.00231.x

    Article  CAS  PubMed  Google Scholar 

  6. Giglioli C, Landi D, Cecchi E, Chiostri M, Gensini GF, Valente S, Ciaccheri M, Castelli G, Romano SM (2011) Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. Eur J Heart Fail 13(3):337–346. doi:10.1093/eurjhf/hfq207

    Article  PubMed  Google Scholar 

  7. Bart BA, Goldsmith SR, Lee KL, Givertz MM, O’Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM et al (2012) Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367(24):2296–2304. doi:10.1056/NEJMoa1210357

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Marenzi G, Muratori M, Cosentino ER, Rinaldi ER, Donghi V, Milazzo V, Ferramosca E, Borghi C, Santoro A, Agostoni P (2014) Continuous ultrafiltration for congestive heart failure: the CUORE trial. J Card Fail 20(1):9–17. doi:10.1016/j.cardfail.2013.11.004

    Article  PubMed  Google Scholar 

  9. Costanzo MR, Negoianu D, Jaski BE, Bart BA, Heywood JT, Anand IS, Smelser JM, Kaneshige AM, Chomsky DB, Adler ED et al (2016) Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC Heart Fail 4(2):95–105. doi:10.1016/j.jchf.2015.08.005

    Article  PubMed  Google Scholar 

  10. Higgins JPT, Deeks JJ (eds) (2011) Chapter 7: selecting studies and collecting data. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from www.cochrane-handbook.org. http://handbook.cochrane.org/chapter_7/7_selecting_studies_and_collecting_data.htm (Last Accessed 15 Mar 2016)

  11. Chung ES, O’Brien TM, Menon S, Bartone C, Mazur W, Kereiakes DJ (2014) A pilot study of target weight guided treatment in acute heart failure using ultrafiltration or usual care: effect on sodium removal. Korean Circ J 44(3):156–161. doi:10.4070/kcj.2014.44.3.156

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Rogers HL, Marshall J, Bock J, Dowling TC, Feller E, Robinson S, Gottlieb SS (2008) A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail 14(1):1–5. doi:10.1016/j.cardfail.2007.09.007

    Article  CAS  PubMed  Google Scholar 

  13. Gheorghiade M, Filippatos G (2005) Reassessing treatment of acute heart failure syndromes: the ADHERE Registry. Eur Heart J Suppl 7(Suppl. B):B13–B19. doi:10.1093/eurheartj/sui008

    Article  Google Scholar 

  14. Colombo PC, Onat D, Harxhi A, Demmer RT, Hayashi Y, Jelic S, LeJemtel TH, Bucciarelli L, Kebschull M, Papapanou P et al (2014) Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur Heart J 35(7):448–454. doi:10.1093/eurheartj/eht456

    Article  CAS  PubMed  Google Scholar 

  15. Guazzi MD, Agostoni P, Perego B, Lauri G, Salvioni A, Giraldi F, Matturri M, Guazzi M, Marenzi G (1994) Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J 72(6):534–539

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Fallick C, Sobotka PA, Dunlap ME (2011) Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation. Circ Heart Fail 4(5):669–675

    Article  PubMed  Google Scholar 

  17. Testani JM, Brisco MA, Kociol RD, Jacoby D, Bellumkonda L, Parikh CR, Coca SG, Tang WH (2015) Substantial discrepancy between fluid and weight loss during acute decompensated heart failure treatment. Am J Med 128(7):776.e774–783.e774. doi:10.1016/j.amjmed.2014.12.020

    Article  Google Scholar 

  18. Jefferies JL, Bartone C, Menon S, Egnaczyk GF, O’Brien TM, Chung ES (2013) Ultrafiltration in heart failure with preserved ejection fraction: comparison with systolic heart failure patients. Circ Heart Fail 6(4):733–739

    Article  PubMed  Google Scholar 

  19. Costanzo MR, Saltzberg M, O’Sullivan J, Sobotka P (2005) Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 46(11):2047–2051. doi:10.1016/j.jacc.2005.05.099

    Article  PubMed  Google Scholar 

  20. Chen J, Normand SL, Wang Y, Krumholz HM (2011) National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998–2008. JAMA 306(15):1669–1678. doi:10.1001/jama.2011.1474

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Agostoni P, Marenzi G, Lauri G, Perego G, Schianni M, Sganzerla P, Guazzi MD (1994) Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 96(3):191–199

    Article  CAS  PubMed  Google Scholar 

  22. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53(7):589–596. doi:10.1016/j.jacc.2008.05.068

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kazory A, Elkayam U (2014) Cardiorenal interactions in acute decompensated heart failure: contemporary concepts facing emerging controversies. J Card Fail 20(12):1004–1011. doi:10.1016/j.cardfail.2014.09.005

    Article  PubMed  Google Scholar 

  24. Jencks SF, Williams MV, Coleman EA (2009) Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 360(14):1418–1428. doi:10.1056/NEJMsa0803563

    Article  CAS  PubMed  Google Scholar 

  25. Gilstrap LG, Joynt KE (2014) Understanding the relationship between readmission and quality of hospital care in heart failure. Curr Heart Fail Rep 11(4):347–353. doi:10.1007/s11897-014-0209-5

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Florida, P.O. Box 100238, Gainesville, FL, 32610, USA

    Ankur Jain & Nikhil Agrawal

  2. Division of Nephrology, Hypertension and Renal Transplantation, University of Florida, Gainesville, FL, USA

    Amir Kazory

Authors
  1. Ankur Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nikhil Agrawal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amir Kazory
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ankur Jain.

Ethics declarations

Funding sources

No specific financial support was obtained for preparation of this article.

Disclosures

The authors have no potential conflict of interest to declare with respect to this paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jain, A., Agrawal, N. & Kazory, A. Defining the role of ultrafiltration therapy in acute heart failure: a systematic review and meta-analysis. Heart Fail Rev 21, 611–619 (2016). https://doi.org/10.1007/s10741-016-9559-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-016-9559-2

Keywords

Search

Navigation